Food & Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food & Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Baxter Healthcare Corp.
Nanoparticle-formulation of drugs can be administered by several routes
September 24th, 2004
Nanoparticles allow a single formulation to be used to develop multiple dosage forms, researchers report. According to published research from the United States, "Formulation development during early drug discovery and lead optimization, involves several challenges including limited drug supply, the need for rapid turnaround, and limited development time." "It is also desirable to develop initial formulations that will be representative of final commercial formulations," wrote M.V. Chaubal and colleagues, Baxter Healthcare Corp., Round Lake. "Nanoparticles offer a unique platform for the formulation of poorly soluble drugs; such...
Source: Food & Drug Law Weekly (2004-09-24)
|
